Lupus & antiphospholipid syndrome

Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment

Clin Exp RheumatolPublished Discrete choice experiment

Authors' conclusion

These DCEs highlight a high degree of awareness among lupus-treating physicians, with no differences across medical specialties, of the unmet need for early diagnosis and prevention of damage accrual in SLE management.

Study context

Population
Clinicians involved in systemic lupus erythematosus (SLE) management (57% females, 71% rheumatologists)115 invited
Participants
95 clinicians
Outcome
Physicians' preferences (relative importance of attributes) on diagnostic pathways and treatment priorities for SLE
Methodological detailsphysician-based, expert-board-defined profiles, Board of 11 SLE experts and a discrete choice experiment (DCE) expert statistician defined profiles
  • Physician-based
  • Expert-board-defined profiles
  • Board of 11 SLE experts and a DCE expert statistician defined profiles

Main finding

As reported in the abstract

Referral time to a rheumatologist, mild-moderate SLE (relative importance (RI))
25%
Referral time to a rheumatologist, severe SLE (RI)
20%
Effect on organ damage progression after 12 months, mild-moderate SLE (RI)
35%
Effect on organ damage progression after 12 months, severe SLE (RI)
41%
Reduction in disease activity levels after 6 months (max RI)
19%
GC dose reduction after 6 months (max RI)
13%
Prednisone <5 mg/day, mild-moderate SLE (PW)
66.1
Prednisone <5 mg/day, severe SLE (PW)
14.2
Administration route, action rapidity, patient-global assessment, serious infection risk (RI)
7-8%

Further findings

Subgroups by clinicians' areas of expertise

No distinctions found among subgroups

Original publication

Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment. Clin Exp Rheumatol. Published 7 March 2024. doi:10.55563/clinexprheumatol/25a2qk

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.